Compare PROF & LTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PROF | LTRX |
|---|---|---|
| Founded | N/A | 1989 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Communications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.8M | 236.4M |
| IPO Year | 2017 | 2000 |
| Metric | PROF | LTRX |
|---|---|---|
| Price | $6.80 | $5.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $12.00 | $6.50 |
| AVG Volume (30 Days) | 139.4K | ★ 663.5K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $16,098,000.00 | ★ $122,923,000.00 |
| Revenue This Year | $92.40 | $1.12 |
| Revenue Next Year | $64.10 | $15.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 50.73 | N/A |
| 52 Week Low | $3.92 | $3.41 |
| 52 Week High | $8.95 | $8.75 |
| Indicator | PROF | LTRX |
|---|---|---|
| Relative Strength Index (RSI) | 44.69 | 48.73 |
| Support Level | $6.24 | $5.08 |
| Resistance Level | $7.03 | $6.09 |
| Average True Range (ATR) | 0.45 | 0.35 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 14.57 | 14.76 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.